Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Chidamide	499.54M
Chidamide Growth	7.06%
Sitagliptin	140.16M
Sitagliptin Growth	231.76%
Other Business	13.45M
Other Business Growth	119.14%
Technology Licensing	2.36M
Technology Licensing Growth	-64.42%
Other	2.44M
Other Growth	16.54%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	641.78M
China Growth	25.66%
United States	2.27M
United States Growth	-32.91%
Taiwan	444.57K
Taiwan Growth	-87.06%